Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.32 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17222816 | 1.00 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2ALDH1A1POLB | |
| SCHEMBL17222834 | 1.00 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2ALDH1A1POLB | |
| SCHEMBL15806237 | 1.00 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL16341294 | 0.98 | TAS1R3 (0.31) | TAS1R3TAS1R1TAS1R2ALDH1A1POLB | |
| SCHEMBL17222832 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL16341140 | 0.97 | — | — | |
| SCHEMBL16340855 | 0.94 | — | — | |
| SCHEMBL16341690 | 0.94 | — | — | |
| SCHEMBL16341694 | 0.94 | — | — | |
| SCHEMBL16341734 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9776178-B2 | Ruthenium complexes comprising an asymmetrical unsaturated N-heterocyclic diaminocarbene | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2017-10-03 | — | — | US | disclosed |
| US-9688641-B2 | Process for preparing asymmetrical imidazolium salts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2017-06-27 | — | — | US | disclosed |
| US-9688641-B2 | Process for preparing asymmetrical imidazolium salts | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2017-06-27 | — | — | US | disclosed |
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | Ecole National Superieure de Chimie de Rennes (FR) | 2015-11-19 | — | — | US | disclosed |
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | Ecole National Superieure de Chimie de Rennes (FR) | 2015-11-19 | — | — | US | disclosed |
| US-20150315223-A1 | Ruthenium Complexes Comprising an Asymmetrical Unsaturated N-Heterocyclic Diaminocarbene | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (FR) | 2015-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329494-A1 | Process for Preparing Asymmetrical Imidazolium Salts | HRH4, F12, ADH1A | TAS1R3 1411/4885TAS1R1 956/4885TAS1R2 1547/4885 |
| US-20150315223-A1 | Ruthenium Complexes Comprising an Asymmetrical Unsaturated N-Heterocyclic Diaminocarbene | ORC3, RFC3, NCOA3 | TAS1R3 1519/4885TAS1R1 2561/4885TAS1R2 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.